Plc Glaxosmithkline

LONDON -- The Beginners' Portfolio made its first buy, of Vodafone Group Plc (ADR) (NASDAQ:VOD) shares, on May 18, 2012 -- and the first anniversary of the fateful day will be here on Saturday. So how...... (read more)

I admit to not being a big fan of many of her movies -- possibly the only man on the planet who will admit so -- but there's little denying that movie sensation Angelina Jolie has a history of selfless...... (read more)

LONDON -- In my previous pick-of-the-sector report, I went for GlaxoSmithKline in the pharmaceuticals sector, and today I'm turning my attention to the banking industry. There are some who wouldn't trust...... (read more)

AstraZeneca plc (ADR) (NYSE:AZN)'s in a tight spot. The big pharma's sales and earnings have swung sharply lower recently, with patent expirations and generic competition slamming the company's revenue...... (read more)

As part of the split, the pharmaceutical company looks poised to turn its current drug-marketing joint venture with London-based GlaxoSmithKline plc (ADR) (NYSE:GSK) into an independent firm. Meanwhile...... (read more)

Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2. The biotech announced earnings of $0.48 per share while analysts were expecting $0.50 per share...... (read more)

Back towards the end of April 2013, Theravance Inc (NASDAQ:THRX) surprised everyone when it announced plans to split into two separate companies. The two companies will split its independent biopharmaceuticals...... (read more)

LONDON -- The FTSE 100 set a five-and-a-half-year record of 6,638 points last Friday, and though the index is down from that today at 6,617, it still looks like hanging on to the 6,600 level -- even...... (read more)

Overall, the market is seeing red today. The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is down 36 points as of 11 a.m. EDT, with little momentum to push it higher. After closing above 15,000...... (read more)